Identical Brains (IDENTICAL)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹21.7
Market Cap₹26.65 Cr
P/E Ratio9.13
ROCE23.43%
ROE—%
Dividend Yield0%
Profit Growth-43.15%
Debt/Equity—
Sales Growth-16.51%
Promoter Holding63.74%
52-Week Range₹14.1 — ₹23.7
SectorEntertainment

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As I sit with the numbers for Identical Brains, my first thought is caution. Charlie and I always say that the margin of safety comes from understanding the business, but here I am given insufficient data. No book value, no ROE, no debt-equity. What I can see is a tiny media and entertainment company with a market cap of ₹27 crore and a P/E of 9.13. That looks cheap, but cheap can become cheaper when the business is shrinking. Sales are down 16.51% and profits have fallen a steep 43.15%. The Piotroski F-score of 3 out of 9 reinforces my worry — this is not a financially healthy business. The latest quarter shows sales of ₹10 crore and net profit of ₹1 crore, implying a 10% margin, but with declining revenue, that margin may not hold. The ROCE of 23.43% is a bright spot, showing the capital employed is earning well, but if the business keeps contracting, that return will erode. There is zero dividend, so the only way I make money is if the market reprices the stock after a genuine recovery. Promoter holding of 63.74% is good — their interests are aligned with mine — but alignment does not create a moat. This is a potential turnaround, but a turnaround requires evidence of stabilization: sales flattening, profit growth turning positive, and a stronger Piotroski score. Without those, I would rather stay with businesses I can value even at a premium. A low P/E on a declining earnings base is often a value trap, and this one has too many red flags for me to invest today.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer